Searched for
ASTRAZENECA OXFORD UNIVERSITY
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...
- Two AstraZeneca COVID shots could be 85-90% effective, UK real-world data suggestPHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but c...
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...
- Oxford study indicates AstraZeneca effective against Brazil variant, source saysThe data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...
- UK to receive 10 million AstraZeneca doses from Serum InstituteSII, the world’s largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for d...
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...
- AstraZeneca, Oxford expect 'next generation' COVID-19 vaccine to tackle variants by autumn - executiveAsked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said "as ra...
- Britain approves AstraZeneca/Oxford COVID-19 vaccineRegulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...
- AstraZeneca's Covid-19 vaccine has a 'winning formula': Chief executive Pascal SoriotThe UK government announced on December 23 that the developers of the Oxford AstraZeneca vaccine had submitted their data to the Medicines ...
- Oxford/AstraZeneca in ‘mix-match' COVID-19 vaccine trial with Russia's SputnikThe two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...
- AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum InstituteVaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and eff...
- Oxford COVID-19 vaccine produces immune response among elderly and young, AstraZeneca saysA vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people,...
- Will resume COVID-19 vaccine trials after DCGI nod: Serum InstitutePharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
- Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford's COVID 'vaccine'The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials...
Load More
